Resonant Capital Advisors LLC Has $319,000 Stock Holdings in Centene Co. (NYSE:CNC)

Resonant Capital Advisors LLC raised its holdings in shares of Centene Co. (NYSE:CNC) by 7.5% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 4,305 shares of the company’s stock after purchasing an additional 301 shares during the quarter. Resonant Capital Advisors LLC’s holdings in Centene were worth $319,000 at the end of the most recent reporting period.

Other hedge funds have also added to or reduced their stakes in the company. Coppell Advisory Solutions Corp. acquired a new stake in Centene during the 4th quarter valued at $25,000. Turtle Creek Wealth Advisors LLC acquired a new stake in Centene during the 4th quarter valued at $25,000. Operose Advisors LLC acquired a new stake in Centene during the 3rd quarter valued at $25,000. OFI Invest Asset Management bought a new position in Centene during the 3rd quarter worth $26,000. Finally, Headinvest LLC acquired a new stake in shares of Centene during the third quarter worth $35,000. Institutional investors and hedge funds own 93.63% of the company’s stock.

Insider Transactions at Centene

In other news, Director Lori Jean Robinson sold 10,000 shares of the business’s stock in a transaction dated Tuesday, February 13th. The stock was sold at an average price of $77.41, for a total transaction of $774,100.00. Following the sale, the director now directly owns 11,455 shares in the company, valued at $886,731.55. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. In related news, President Kenneth J. Fasola sold 12,000 shares of the company’s stock in a transaction that occurred on Wednesday, February 7th. The stock was sold at an average price of $75.07, for a total value of $900,840.00. Following the sale, the president now directly owns 235,365 shares in the company, valued at $17,668,850.55. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Director Lori Jean Robinson sold 10,000 shares of the company’s stock in a transaction that occurred on Tuesday, February 13th. The shares were sold at an average price of $77.41, for a total value of $774,100.00. Following the completion of the sale, the director now owns 11,455 shares in the company, valued at $886,731.55. The disclosure for this sale can be found here. Company insiders own 0.33% of the company’s stock.

Analyst Upgrades and Downgrades

CNC has been the subject of a number of research reports. StockNews.com downgraded Centene from a “strong-buy” rating to a “buy” rating in a report on Thursday, March 28th. Wells Fargo & Company lifted their target price on Centene from $89.00 to $93.00 and gave the stock an “overweight” rating in a report on Monday, April 15th. Stephens reissued an “equal weight” rating and set a $85.00 target price (down previously from $92.00) on shares of Centene in a report on Thursday, March 21st. Cantor Fitzgerald reissued an “overweight” rating and set a $90.00 target price on shares of Centene in a report on Thursday, April 4th. Finally, Barclays initiated coverage on Centene in a research note on Wednesday, March 6th. They issued an “overweight” rating and a $101.00 price target for the company. Five analysts have rated the stock with a hold rating and seven have given a buy rating to the stock. According to data from MarketBeat.com, Centene presently has a consensus rating of “Moderate Buy” and an average target price of $85.38.

Centene Stock Up 1.9 %

Shares of NYSE CNC opened at $75.15 on Friday. The company has a current ratio of 1.11, a quick ratio of 1.11 and a debt-to-equity ratio of 0.68. The company has a market cap of $40.20 billion, a price-to-earnings ratio of 15.31, a PEG ratio of 0.92 and a beta of 0.38. Centene Co. has a 12 month low of $60.83 and a 12 month high of $81.42. The stock has a 50-day moving average price of $76.56 and a two-hundred day moving average price of $74.61.

Centene (NYSE:CNC) last issued its earnings results on Tuesday, February 6th. The company reported $0.45 EPS for the quarter, topping the consensus estimate of $0.43 by $0.02. The firm had revenue of $39.46 billion during the quarter, compared to the consensus estimate of $36.16 billion. Centene had a return on equity of 14.26% and a net margin of 1.75%. The business’s quarterly revenue was up 11.0% on a year-over-year basis. During the same quarter in the previous year, the firm earned $0.86 earnings per share. As a group, analysts forecast that Centene Co. will post 6.75 earnings per share for the current fiscal year.

Centene Profile

Centene Corporation operates as a healthcare enterprise that provides programs and services to under-insured and uninsured families, commercial organizations, and military families in the United States. The company operates through Medicaid, Medicare, Commercial, and Other segments. The Medicaid segment offers health plan coverage, including medicaid expansion, aged, blind, disabled, children's health insurance program, foster care, medicare-medicaid plans, long-term services and support.